ImClone lowers earnings to cover CEO’s tax bill
Biotech company ImClone announced last week that it is delaying the announcement of its financial results and may be forced to restate its earnings from 2001 onwards to cover the unpaid taxes of its former chief executive
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: